- Lobbying
- John AND Coster
Lobbying Arrangements Results for 'John Coster'
Former Covered Federal Workers:
Other Lobbyists:
Issue | Client | Firm | Lobbyists | Start Date | Latest Filing Date |
---|---|---|---|---|---|
Details Pharmacy provider status issues, particularly HR 4190, Medicare Coverage of Pharmacy Services |
American Society of Health System Pharmacists
|
Mr. John Coster | |||
Details medication therapy management legislation,particulary HR 1024 and S 557 |
Horizon Government Affairs
|
Mr. John Coster | |||
Details pharmaceutical and health care product distribution issues, Medicare Part B and D issues, Medicaid pharmacy issues, HR 800, S. 806, HR 4709, Ensuring Patient Access and Effective Drug Enforcement A... |
AmeriSource Bergen
|
Mr. John Coster | |||
Details Implementation issues related to the American Rescue Plan Act of 2021 (Pub. L. No. 117-2). H.R. 5376, Build Back Better Act, provisions related to health care. S. 4293, Pharmacy Benefit Manager Tr... |
Rite Aid Corporation
|
in-house lobbying | |||
Details Issues related to drug pricing, drug shortages, and the drug supply chain, including support for the following bills: the Protecting Patients Against PBM Abuses Act (H.R. 2880), the Transparency an... |
American Society of Health-System Pharmacists
|
in-house lobbying | |||
Details Prescription Drug Costs. H.R.5429/S.2780: Medication Affordability and Patent Integrity Act. 180-Day Exclusivity. S.1114: Expanding Access to Low-Cost Generics Act of 2023. H.R.5461/S.2129: Ensurin... |
Association for Accessible Medicines
|
in-house lobbying | |||
Details H.R. 501, the Block, Report, and Suspend Suspicious Shipments Act; S. 2666, the E-Prescribing Parity for Controlled Substances Act Remote Prescribing of Controlled Substances H.R. 1613 / S. 1038, t... |
National Community Pharmacists Association
|
in-house lobbying | |||
Details H.R. 501 Block, Report, And Suspend Suspicious Shipments Act H.R. 895 Combating Organized Retail Crime Act H.R. 1613 Drug Price Transparency in Medicaid Act 2023 H.R. 1770 The Equitable Community A... |
NATIONAL ASSOCIATION OF CHAIN DRUG STORES
|
in-house lobbying | |||
Details The 340B Drug Pricing Program; The Protect 340B Act; FY24 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations bill. HR 3290,to amend title III of th... |
340B Health
|
in-house lobbying |